Rees, Tayla A.
Tasma, Zoe
Garelja, Michael L.
O’Carroll, Simon J.
Walker, Christopher S.
Hay, Debbie L.
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (RF1NS113839, RF1NS113839, RF1NS113839, RF1NS113839, RF1NS113839)
Neurological Foundation of New Zealand
Article History
Received: 18 January 2024
Accepted: 5 March 2024
First Online: 14 March 2024
Declarations
:
: Male and female Sprague Dawley (SD) rats and C57BL/6J mouse DRG for Figs. InternalRef removed, InternalRef removed and InternalRef removed, InternalRef removed C and E, and Neonatal Wistar rats for Fig. InternalRef removedF, were obtained from the Integrated Physiology Unit (University of Auckland, Auckland, New Zealand). All procedures involving the use of animals were conducted in accordance with the New Zealand Animal Welfare Act (1999) and approved by the University of Auckland Animal Ethics Committee. Male and female Sprague Dawley (SD) rat DRG for Fig. InternalRef removedA were obtained from the Biomedical Research Facility (University of Otago, Dunedin, New Zealand). All procedures involving the use of animals were conducted in accordance with the New Zealand Animal Welfare Act (1999) and approved by the University of Otago Animal Ethics Committee.Post-mortem human DRG were obtained from the University of Auckland Human Anatomy Laboratory, with informed consent by the donor before death and next of kin after death as part of the University of Auckland Human Body Bequest Program for teaching and research. This program and its procedures operate under the Human Tissue Act of 2008 and are overseen by the New Zealand Police Inspector of Anatomy.
: D.L.H. has received research support from AbbVie, and has acted as an advisor, speaker or consultant for Amgen, Sosei-Heptares, Teva and Eli Lilly. C.S.W. has received research support from AbbVie. No other authors have conflicts of interest connected to this paper.